MedPath

rTMS-induced Cumulative Pattern of sBDNF in Chronic Schizophrenia

Not Applicable
Completed
Conditions
Schizophrenia
Interventions
Device: CR Technology, TAMAS for repetitive TMS
Registration Number
NCT01427088
Lead Sponsor
Jeonbuk Provincial Maeumsarang Hospital
Brief Summary

This study aims at investigating the neuroplastic potential and the possible factors affecting rehabilitation in chronic schizophrenia patients on stable medication, by investigating the cumulative pattern of serum BDNF representing the neuroplasticity in the brain, through quantitative stimulus such as rTMS.

Detailed Description

Subjects who have been enrolled for this study will take baseline evaluation for sociodemographic data and serum level of BDNF, plasma Prolaction, and magnesium, etc. And then, weekday regular stimulation through rTMS will be applied on DLPFC of brain. After the completion of stimulation for 2 weeks, the change or response of serum BDNF will be analyzed and compared.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • duration of illness over 10 years
  • on stable medication, antipsychotics
  • no change on medication within at least 2 weeks
  • Diagnosis of Schizophrenia according to DSM-IV-TR
Exclusion Criteria
  • left or both-handedness
  • anticonvulsant use
  • lorazepam equivalent over 3 mg

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
repetitive TMSCR Technology, TAMAS for repetitive TMSrepetitive TMS is a quantified stimulation method of specifie area of brain, for which CR Technology, TAMAS for repetitive TMS was used.
Primary Outcome Measures
NameTimeMethod
change from baseline of serum BDNF concentrationbaseline-1 week-2 week-4 week
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Jeonbuk Provincial Maeumsarang Hospital

🇰🇷

Wanju, Jeonbuk, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath